Immunocore Holdings Ltd (IMCR) — Cash Flow Reinvestment Rate
Immunocore Holdings Ltd (IMCR) has a Cash Flow Reinvestment Rate of 1.19x as of June 2025, reinvesting $30.83 Million (capex $414.00K plus investments $-30.41 Million) from operating cash flow of $25.96 Million. Check cash flow quality index of Immunocore Holdings Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Immunocore Holdings Ltd Cash Flow Reinvestment Rate (2023–2024)
Historical reinvestment intensity for Immunocore Holdings Ltd across 2 annual periods. Explore long-term investment intensity of Immunocore Holdings Ltd to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Immunocore Holdings Ltd (2023–2024)
Year-by-year capital reinvestment analysis for Immunocore Holdings Ltd. For live market cap and broader valuation context, see market cap of Immunocore Holdings Ltd.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 13.83x | $360.30 Million | $26.06 Million | $5.17 Million | ▲ +298.1% |
| 2023 | 3.47x | $10.21 Million | $2.94 Million | $5.42 Million | — |